CYCN
Cyclerion Therapeutics Inc

7,590
Loading...
Loading...
News
all
press releases
News Placeholder
Why Did Cyclerion Therapeutics Stock Surge Nearly 50% After-Hours Today?
The biotech is relaunching as a neuropsychiatric company, anchored by an MIT licensing deal and a lead program in treatment-resistant depression.
Stocktwits·13d ago
News Placeholder
Critical Comparison: Cyclerion Therapeutics (NASDAQ:CYCN) and Bellicum Pharmaceuticals (NASDAQ:BLCM)
Bellicum Pharmaceuticals (NASDAQ:BLCM Get Free Report) and Cyclerion Therapeutics (NASDAQ:CYCN Get Free Report) are both small-cap medical companies, but which is the superior stock...
Zolmax·2y ago

Latest CYCN News

View

Advertisement|Remove ads.

Advertisement|Remove ads.